<code id='437283B7CC'></code><style id='437283B7CC'></style>
    • <acronym id='437283B7CC'></acronym>
      <center id='437283B7CC'><center id='437283B7CC'><tfoot id='437283B7CC'></tfoot></center><abbr id='437283B7CC'><dir id='437283B7CC'><tfoot id='437283B7CC'></tfoot><noframes id='437283B7CC'>

    • <optgroup id='437283B7CC'><strike id='437283B7CC'><sup id='437283B7CC'></sup></strike><code id='437283B7CC'></code></optgroup>
        1. <b id='437283B7CC'><label id='437283B7CC'><select id='437283B7CC'><dt id='437283B7CC'><span id='437283B7CC'></span></dt></select></label></b><u id='437283B7CC'></u>
          <i id='437283B7CC'><strike id='437283B7CC'><tt id='437283B7CC'><pre id='437283B7CC'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:596
          Photograph of Ron DeSantis pointing. -- health policy coverage from STAT
          Florida Gov. and GOP presidential candidate Ron DeSantis wants to import Canadian prescription drugs. Charlie Neibergall/AP

          WASHINGTON — Florida governor and presidential hopeful Ron DeSantis has ballyhooed a high-profile plan to import prescription drugs from Canada, even suing the Biden administration for allegedly holding up a necessary sign-off.

          But the plan’s long odds just got longer: the Food and Drug Administration said in a letter last week that Florida’s plan has gaping holes — and the state has less than a week to explain how it’ll fix them.

          advertisement

          The FDA “identified several deficiencies,” in the drug-import plan, it said. Despite its thousands of pages, the plan does not show whether it meets the two overarching requirements of saving money and securing the drug supply chain, the agency explained. The FDA gave the state until August 28 to flesh out those two subjects.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Roche’s Alnylam deal shows drug firms interested in heart drugs
          Roche’s Alnylam deal shows drug firms interested in heart drugs

          AdobeRoche’sannouncementMondaythatitwouldpay$310millionforrightstoahypertensiontreatment,zilebesiran

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Ford recalls 870K F

          FILE-A2021F-150pickuptruckataForddealerinsoutheastDenver,Oct.24,2021.Fordisrecallingmorethan870,000n